triple-negative breast cancer

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:Oncology
gptkbp:advocacy	important for support important for awareness important for research funding
gptkbp:associated_with	gptkb:BRCA1_mutations BRCA2 mutations
gptkbp:characterized_by	lack of estrogen receptors lack of progesterone receptors lack of HER2 protein
gptkbp:clinical_trial	ongoing studies combination therapies new drug therapies
gptkbp:death	varies by stage lower than hormone receptor-positive breast cancer
gptkbp:diagnosis	biopsy imaging tests generally poorer than other types of breast cancer
gptkbp:events	may include blood tests important for monitoring recurrence may include regular imaging
gptkbp:genetic_studies	recommended for high-risk individuals
gptkbp:has_tour	Stage I Stage II Stage III Stage IV
https://www.w3.org/2000/01/rdf-schema#label	triple-negative breast cancer
gptkbp:is_common_in	African American women younger women
gptkbp:is_involved_in	available for patients
gptkbp:public_awareness	focused on education focused on early detection focused on research funding
gptkbp:research_focus	gptkb:immunotherapy targeted therapy
gptkbp:risk_factor	obesity exposure to radiation lack of physical activity family history of breast cancer
gptkbp:symptoms	changes in breast shape lump in the breast nipple discharge
gptkbp:treatment	gptkb:surgery radiation therapy chemotherapy
gptkbp:bfsParent	gptkb:Tecentriq
gptkbp:bfsLayer	5